10x Genomics (FRA:1KJ) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1KJ 10x Genomics Inc FRA:1KJ
60 GF Score
Price €38.21
GF Value €16.52
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is 10x Genomics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

10x Genomics Valuation Rank Related Terms

FRA:1KJ
60GF Score
10x Genomics Inc FRA:1KJ
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 10x Genomics (FRA:1KJ) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of €38.21 is trading 131.3% above its estimated GF Value™ of €16.52. GuruFocus considers 10x Genomics to be Significantly Overvalued.

Key valuation signals for FRA:1KJ:

  • Valuation Rank:
  • GF Value™: €16.52 vs. price of €38.21 (131.3% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the FRA:1KJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges TXG:USA0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
60GF Score

Get the complete analysis for FRA:1KJ

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€38.21
Price
€16.52
GF Value